Research into bone cancers and related disorders have explored the role that B7-H3 may have in their progression, predominantly focusing on the relationship between B7-H3 and MMP activity, but our results indicate that B7-H3 could influence bone disorders by enhancing BMP signaling, leading to hyperactive bone cell proliferation or migration [73]. Here, CD276 is linked to bone neoplasm.